• Aucun résultat trouvé

60 59

N/A
N/A
Protected

Academic year: 2022

Partager "60 59"

Copied!
44
0
0

Texte intégral

(1)

Fig. 59 Malignant phaeochromocytoma, hepatic metastasis.

X 120

Fig. 60 Malignant sympathetic paraganglioma, lymph node metastasis

Primary in bladder. x 1 20

Hypertension

Hypertension

(2)

Fig. 61 Malignant parasympathetic paraganglioma, carotid body

local invasion and lymph node metastasis occurred. x 75

Fig. 62 Neuroblastoma, adrenal medulla

X 120

(3)

Fig. 63 Neuroblastoma, adrenal medulla

Neurofibrillary area. x 300

Fig. 64 Mixed neuroendocrine-neural tumour, adrenal medulla

Ganglioneuromatous area. Fig. 64 to 66 are from same case.

X 120

Hypertension

(4)

Fig. 65 Mixed neuroendocrine-neural tumour, adrenal medulla

Partly ganglioneuromatous, partly diffuse phaeochromocy- toma (centre of field). x 120

Fig. 66 Mixed neuroendocrine-neural tumour, adrenal medulla

Area of malignant phaeochromocytoma with mitotic activity.

X 300

Hypertension

Hypertension

(5)

Fig. 67 Adenoma, parathyroid

Adenoma with attached normal gland and thyroid. x 5

.,.,,

~""' ·:~ "":':

. .

~,

1",}

' -·

,,

~::\

't~~

~-

-f't;t~"l:

Fig. 68 Chief cell adenoma, parathyroid Rim of suppressed gland. x 120

Hyperparathyroidism

Hyperparathyroidism

(6)

Fig. 69 Chief cell adenoma, parathyroid Nuclear pleomorphism. X 120

Fig. 7Q Chief cell adenoma, parathyroid Follicular architecture simulates thyroid. x 120

Hyperparathyroidism

Hyperparathyroidism

(7)

Fig. 71 Chief cell adenoma, parathyroid

Portion of fibrous wall of cystic tumour. x 50

Fig. 72 Water-clear cell adenoma, parathyroid

Rim of inactive chief cells with some oxyphils. x 30

Hyperparathyroidism

Hyperparathyroidism

(8)

Fig. 73 Oxyphil cell adenoma, parathyroid

Abundant granular eosinophilic cytoplasm. x 300

Fig. 74 Inactive parathyroid gland

Small chief cells, fat. Same case as Fig. 70. x 300

Hyperparathyroidism

(9)

Fig. 75 Carcinoma, parathyroid Hyperparathyroidism Broad trabecular pattern, fibrous bands. X 50

Fig. 76 Carcinoma, parathyroid Hyperparathyroidism

Invasion of muscle and vessels at edge of tumour. X 50

(10)

, ,

~

' - #

if~

... ' '

' ._.}._-.,. .. ~~- ... '

Fig. 77 Carcinoma, parathyroid

Vascular invasion. X 120

Fig. 78 Carcinoma, parathyroid

Uniform cells, mitotic activity. x 75 '

~'

'

Hyperparathyroidism

Hyperparathyroidism

(11)

~ '-.

·-;_;>'-·

~-.·~·\~

Fig. 79 Lipoadenoma, parathyroid

Section of 5 cm tumour. x 50

Fig. 80 Primary nodular hyperplasia, parathyroids

Large upper, small lower glands. x 3

' '

·.•

Hyperparathyroidism

Hyperparathyroidism, MEN I

(12)

Fig. 81 Primary nodular hyperplasia, parathyroid

Chief and oxyphil cell nodules. x 50

Fig. 82 Primary nodular hyperplasia, parathyroid

Multiple ill-defined oxyphil cell nodules. x 50

Hyperparathyroidism. MEN I

Hyperparathyroidism. MEN I

(13)

Fig. 83 Primary nodular hyperplasia, parathyroid Nodules of differing architecture and cell type. X 120

:~

...

·~....

: ... ,.., ...

--,

... · :.·

k .., ... .,,., , . .. • • ,. .. . ~.·:-·.,

J.·.~· .. ~-; : .. ~ .. !.'• ~; •• : ...•.••. · •. • ... . .• :

• . : •

·.~··

....

~

."-. r ... ... ... . ••' .-.':--·..

··~

.. •• • .

! ·~ •

il,

~tl. . . ,.._.. • ••• ·- : :: ·--::·~-· •• . , .-

. ~-~·"··,-... ~"'·"'···~ , . . •"4:

.~ • "' ~ • Jl • -._ 11 . • • ·• • •: "' : !t:" I , ... •.,.., • •"

.:- ..

,~~

. . ,.,·:· .: . · ..

;

. ... .

~

.. ' .

~

... ·: . ' . . ....

Fig. 84 Primary water-clear cell hyperplasia, parathyroid.

X 120

Hyperparathyroidism

Hyperparathyroidism

(14)

Fig. 85 Secondary hyperplasia, parathyroid Uniform appearance found in all glands. Renal failure. X 30

Fig. 86 Secondary hyperplasia, parathyroids Long-standing renal failure. Early nodularity in one gland.

X 3

Secondary hyperparathyroidism

Secondary hyperparathyroidism

(15)

Fig. 87 Nodular hyperplasia, parathyroids

Nodularity in all glands. Hypercalcaemia and long-standing renal failure. x 3

Fig. 88 Adenomas, parathyroids

Two adenomas and two suppressed glands. Hypercalcaemia and long-standing renal failure. x 3

Tertiary hyperparathyroidism

Tertiary hyperparathyroidism

(16)

Fig. 89 Nodular hyperplasia, parathyroid

Hypercalcaemia and renal failure. x 12

Fig. 90 Nodular hyperplasia, parathyroid

Oxyphil and chief cell nodules. x 50

Tertiary hyperparathyroidism

Tertiary hyperparathyroidism

(17)

Fig. 91 EC-cell carcinoid, ileum

Mainly submucosal tumour extending through thickened muscle to serosa. x 5

Fig. 92 EC-cell carcinoid, ileum

Solid islands of cells in a fibrous stroma. X 50

(18)

Fig. 93 EC-cell carcinoid, ileum

Submucosal tumour. Islands of cells with glandular differen- tiation. x 50

Fig. 94 EC-cell carcinoid, appendix

Islands and strands of tumour in fibrous stroma. x 120

I •

·- .

(19)

Fig. 95 EC-cell carcinoid, appendix

Oiazo-positivity most marked in basigranular peripheral cells.

Alkaline diazonium. X 120

Fig. 96 EC-cell carcinoid, ileum

Carcinoid invading mucosa. Note distinction between normal Paneth cells and eosinophilic granular tumour cells. x 300

(20)

• • • •

Fig. 97 EC-cell carcinoid, ileum

I

"'

-

~.

Same case and area as Fig. 96. Masson-Fontana. X 300

.

'

"'

. .. .

\

..

.,

Fig. 98 EC-cell carcinoid, ileum

Same case and area as Fig. 96. Bodian. x 300

(21)

Fig. 99 EC-cell carcinoid, ileum Carcinoid syndrome Hepatic metastasis, partial cystic change. Grimelius x 120

Fig. 100 G-cell tumour, pancreas Zollinger-EIIison syndrome Trabecular pattern. Tumour metastasized. MEN I. x 120

(22)

Fig. 101 G-cell tumour, pancreas Mitotic activity. X 300

Fig. 1 02 G-cell tumour, pancreas

Argyrophilic cells. Small tumour in MEN I. Grimelius. X 120

Zollinger-EIIison syndrome

Zollinger-EIIison syndrome

(23)

Fig. 103 G-cell tumour, pancreas Argyrophilic cells. Grimelius. x 300

Fig. 1 04 Bronchial carcinoid

Regular cells, granular cytoplasm. x 300

Zollinger-EIIison syndrome

(24)

Fig. 1 05 Bronchial carcinoid

Solid islands of cells. Resemblance to classic carcinoid pattern. Same case as Fig. 1 07 and 1 OB. x 120

Fig. 1 06 Bronchial carcinoid

Ribbon pattern, same case as Fig. 1 04. x 300

(25)

Fig. 107 Bronchial carcinoid

Encroaching on bronchial lumen. Diffuse pattern. x 120

Fig. 1 08 Bronchial carcinoid

Scattered argyrophilic cells. Same case and area as Fig.

1 07. Grimelius. X 120

~ :,;' ."':'"!

-

...

(26)

Fig. 109 Bronchial carcinoid

Strongly argyrophilic tumour. Bodian. x 120

Fig. 11 0 Thymic carcinoid X 120

Cushing"s syndrome (ectopic ACTH)

(27)

Fig. 111 Gastric carcinoid X 120

Fig. 112 Gastric carcinoid

Argyrophil cells and glandular structures. Bielschowsky.

X 120

Cushing"s syndrome (ectopic ACTH)

(28)

Fig. 113 Pancreatic carcinoid

X 75

Fig. 114 Pancreatic carcinoid

Grimelius-neutral red. x 190

Verner-Morrison syndrome

Verner-Morrison syndrome

(29)

Fig. 115 Duodenal carcinoid

X 30

Fig. 11 6 Duodenal carcinoid Trabecular pattern. X 120

(30)

Fig. 117 Duodenal carcinoid Argyrophilia. Grimelius. X 120

Fig. 118 Rectal carcinoid

Small submucosal tumour. Trabecular pattern. x 30

(31)

Fig. 119 Rectal carcinoid

Mixed pattern. x 50

Fig. 120 Rectal carcinoid

Ribbon pattern. x 120

(32)

Fig. 121 Gall bladder carcinoid

X 120

Fig. 122 Mucocarcinoid, appendix

Well-differentiated goblet cells invading muscle. X 120

(33)

Fig. 123 Mucocarcinoid, appendix

Isolated argentaffin cells. Masson-Fontana-Mucicarmine.

X 120

Fig. 124 Mucocarcinoid, appendix

Perineural invasion in appendiceal muscle. Argentaffin cells.

Masson-Fontana-Mucicarmine. x 300

(34)

Fig. 125 Mixed carcinoid-adenocarcinoma, rectum

Carcinoid component. X 120

Fig. 126 Mixed carcinoid-adenocarcinoma, rectum

Carcinoma with signet-ring cells. Same tumour as Fig. 1 25.

X 120

(35)

Fig. 127 Mixed carcinoid-adenocarcinoma, rectum

Both patterns of growth. Argyrophil cells.

Bodian-mucicarmine x 120

Fig. 128 Adenocarcinoma, rectum

Scattered EC-cells present. See Fig. 129. x 120

(36)

Fig. 129 Adenocarcinoma, rectum

EC-cells. Same case and area as Fig. 128. Masson- Hamperl. x 120

Fig. 130 Mucinous carcinoma, ovary

Numerous very prominent EC-cells seen in haematoxylin·

eosin section. x 300

(37)

Fig. 131 Normal islets of Langerhans

B cells (purple). Aldehyde fuchsin. x 300

Fig. 1 32 Normal islets of Langerhans

A cells (argyrophilic). Grimelius. X 1 20

(38)

Fig. 133 Islet cell adenoma

8-cell adenoma, trabecular pattern. X 120

Fig. 134 Islet cell adenoma Stromal amyloid. x 120

Hypoglycaemia

(39)

Fig. 135 Islet cell adenoma

B-cell adenoma. x 300

Fig. 136 Islet cell adenoma

B-cell adenoma. x 190

Hypoglycaemia

Hypoglycaemia

(40)

Fig. 137 Islet cell adenoma

Capsule. hyperplastic islets. x 50

Fig. 138 Islet cell adenoma

Clear cells, resemblance to adrenal cortex. x 120

.. ... , '

... .. ..

'

. ....

MEN I

MEN I

(41)

Fig. 139 Islet cell adenoma

B-cell adenoma. Aldehyde fuchsin-positive cells. Aldehyde fuchsin. x 300

Fig. 140 Islet cell carcinoma

B-cell tumour. Stromal fibrosis, calcification and amyloid. X 75

Hypoglycaemia

(42)

Fig. 141 Islet cell carcinoma Hypoglycaemia B-cell tumour. Hepatic metastases occurred. x 190

Fig. 142 Islet cell carcinoma Hypoglycaemia

Liver metastasis. Regular cells, mitotic activity. x 480

(43)

Fig. 143 Poorly differentiated endocrine carcinoma, pancreas

Liver metastasis. x 120

Fig. 144 Poorly differentiated endocrine carcinoma, pancreas

X 300

..

.-

...

~

.. t -;. -

l'' .

. ...

~

Cushing's syndrome (ectopic ACTH)

Hyperglycaemia

(44)

Fig. 145 Islet cell hyperplasia

Large numerous islets in normal exocrine pancreas. x 50

Fig. 146 Islet cell hyperplasia

Chronic pancreatitis. Crowded islets, destroyed exocrine pancreas. x 50

MEN I

Références

Documents relatifs

Un problème important auquel fait face les analystes de risque est comment traiter les incertitudes liées aux paramètres d’un scénario d'accident, tels que la

Une croissance de type polyclonal était généralement tenue pour responsable de ces hyperplasies touchant toutes les parathyroïdes, probablement en réponse à un ou

The trajectory tracking problem of mobile robots in the presence of sliding is solved in [5] using discrete-time sliding mode control, a simple discrete-time model of vehicles

4-MEI not induced apoptosis but, increased annexin-V uptake and elevated expression of activated Caspase3 was observed during high glucose treatment and subsequent treatment of

From what had been learned from the KPS survey, the Acton Sky Portal based exoplanet survey telescope now preferably targets the high star density fields of the Milky Way to

Modelling landscape transformation at the Chalcolithic Tripolye mega-site of Maidanetske (Ukraine): Wood demand and availability.. Marta Dal Corso 1,2 , Wolfgang Hamer 1,3

Nous vous sommes reconnaissant pour toute l'attention bienveillante que vous nous avez accordée pendant notre stage dans votre service et l'honneur que vous nous

We identified HNF1α as a human tumor suppressor gene involved in liver tumorigenesis, as we found biallelic inactivating mutations of this gene in ∼35-50% of HCA as well as a